For medicines with a narrow therapeutic index (e.g., warfarin, digoxin), additional monitoring may be appropriate when starting or stopping GLP-1 therapy
This applies whether youre using brand-name Ozempic, brand-name Wegovy, or compounded semaglutide
Vasquez Law Firm serves clients in both North Carolina and Florida, offering localized expertise within the broader federal framework
Clinical implications of estimated glomerular filtration rate dip following sodiumglucose cotransporter-2 inhibitor initiation on cardiovascular and kidney outcomes
Your health history, current dose, side effects, nutrition, activity level, and drinking habits all matter
Retatrutide, a triple-agonist (GLP-1, GIP and glucagon), is in late-stage trials and has produced even more weight loss in early data up to 24% at 48 weeks in phase 2